• In May 2026, Remodel Health, a leading individual coverage health reimbursement arrangement (ICHRA) provider, announced a new integration in the Paylocity Integration Marketplace that links its benefits platform with Paylocity’s payroll and HR system to automate data syncing for eligibility, enrollment, and contributions.
• This connection tightens the link between payroll and health benefits administration, potentially making Paylocity’s platform more valuable to employers seeking fewer manual processes and better data integrity.
• Next, we’ll explore how this deeper benefits integration could influence Paylocity’s long-term investment narrative built around automation and open APIs.

Explore 28 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

Paylocity Holding Investment Narrative Recap

To hold Paylocity, you need to believe its modern HCM platform can keep adding value for employers even as growth guidance moderates and competition stays intense. The Remodel Health integration looks directionally helpful for the near term by reinforcing Paylocity’s automation and open-API story, but it does not fundamentally change the key near-term catalyst of executing on slower 2026 revenue guidance, nor the risk that large rivals and pricing pressure could weigh on margins and valuation.

Among recent updates, the launch of Paylocity Elevate Solutions in April 2026 ties closely to this benefits integration. Elevate pairs the software with dedicated implementation, payroll, and HR support, aiming to reduce friction for clients that want deeper automation but lack internal resources. Together with marketplace integrations like Remodel Health, Elevate could support cross-sell and stickiness, which matters as management balances ongoing R&D and sales spending with the need to sustain attractive returns on capital.

Yet against these positives, higher pricing pressure in a crowded HCM market could still be a material risk investors should be aware of if...

Paylocity Holding's narrative projects $2.2 billion revenue and $399.6 million earnings by 2029.

Uncover how Paylocity Holding's forecasts yield a $169.43 fair value, a 50% upside to its current price.

Exploring Other Perspectives

While consensus focuses on modest 2026 revenue guidance, the most optimistic analysts were penciling in about US$2.3 billion of revenue and US$445.4 million of earnings by 2029, suggesting far more upside from integrations like Remodel Health than the baseline view. As you weigh these different expectations, it is worth asking how this kind of news might shift either narrative before you decide which camp you find more convincing.

Explore 2 other fair value estimates on Paylocity Holding - why the stock might be worth over 2x more than the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Paylocity Holding research is our analysis highlighting 3 key rewards that could impact your investment decision.
• Our free Paylocity Holding research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Paylocity Holding's overall financial health at a glance.

Want Some Alternatives?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

• The future of work is here. Discover the 35 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 13 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• We've uncovered the 10 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.